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Abstract Programmed cell death, or apoptosis, is a tightly
regulated process mediated by selective cleavage of proteins
by caspases, resulting in ordered destruction of the cell. In
addition to structural proteins, proteins that mediate anti-
apoptotic signal transduction are also substrates; their destruc-
tion eliminates potential futile attempts to escape execution. We
asked whether cAMP response element binding protein (CREB),
a transcription factor that mediates nerve growth factor (NGF)
survival signals, is a target for caspases during apoptosis. CREB
was specifically cleaved by caspases in neuroblastoma extracts,
and in cells induced to undergo apoptosis by staurosporine. The
destruction of CREB eliminates a key factor that could reverse
apoptosis. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Apoptosis, a quick, clean cellular execution, is carried out
through the activation of caspases, which proteolytically
cleave and activate downstream factors that disassemble the
cell, such as the actin-severing protein gelsolin [1] and DNase
(cleavage of ICAD releases the DNase CAD) [2]. Caspases
also inactivate proteins required for survival, such as poly-
ADP-ribose polymerase (PARP) [3] and several anti-apoptotic
signal transduction molecules, including Ras-GAP, Raf-1,
MEKK1, and Akt [4,5]. Since caspase activity plays a role
in the pathogenesis of neurodegenerative disease [6], and cas-
pase inhibition delays progression of neurodegeneration, for
example in mouse models of Huntington’s disease [7], it is of
biological interest to characterise caspase substrates in neural
apoptosis.
CREB (cAMP response element binding protein) regulates
many aspects of neuronal function such as nerve cell excita-
tion, CNS development, long-term memory formation, and
circadian rhythms [8]. CREB plays a key role in regulating
neuronal survival and di¡erentiation in response to neurotro-
phic factors NGF, BDNF, FGF and IGF-1 [9^12]. CREB is
activated as a transcription factor by phosphorylation at Ser-
133, through both the Ras/Raf/Mek/Erk/Rsk and the PI3K/
PDK/Akt pathways [13^16]. Phospho-CREB accumulates in
the nucleus in response to retrograde transport of the NGF
receptor tyrosine kinase, TrkA [17], which is presumably con-
veyed to the cell body via ‘signalling vesicles’ [18]. CREB
appears to be a primary transcriptional activator of the
anti-apoptotic gene, bcl-2 [14,16,19,20]. Inhibition of CREB
activity induces apoptosis in sympathetic neurones [19], while
CREB overexpression inhibits apoptosis induced by okadaic
acid [21].
Many metabolic pathways are regulated in both forward
and reverse directions, which ensures that futile cycles, reac-
tions in both directions simultaneously, do not occur. The
emerging picture is that the regulation of apoptosis follows
the same scheme: signalling proteins that turn o¡ the cell
death programme are selectively destroyed. We now present
evidence that the transcription factor CREB is a target of
caspases during neural apoptosis both in vitro and in vivo.
2. Materials and methods
All reagents were purchased from Sigma (St. Louis, MO, USA)
unless otherwise noted.
2.1. Cell culture and preparation of cytosolic extracts and nuclei
Human neuroblastoma SY5Y cells and rat phaeochromocytoma
PC12 cells were cultured as described [5]. Nuclei and cytosol were
prepared exactly as described [5].
2.2. In vitro reconstitution of apoptosis and visualisation of chromatin
condensation
Aliquots of 40 Wl of SY5Y cytosol (500 Wg protein) were incubated
with 5U106 PC12 nuclei in the absence or presence of 2 WM cyto-
chrome c, 1 WM DEVD-CHO (Biomol, Plymouth Meeting, PA,
USA), 1 WM IETD-CHO (Biomol), 1 WM YVAD-CHO (Biomol),
100 WM z-VAD-fmk (Enzyme Systems Products, Livermore, CA,
USA), 1 mM sodium orthovanadate, 5 WM okadaic acid (Life Tech-
nologies, Gaithersburg, MD, USA), an ATP-regenerating system (8
mM creatine phosphate, 1 mM ATP, and 5 Wg/ml creatine kinase) or
ATP-depleting system (5 mM glucose and 14.2 U/ml hexokinase, Ser-
va, Heidelberg, Germany) and made up to a ¢nal volume of 50 Wl
with cytosol bu¡er. Reactions were incubated at 37‡C for 4 h.
Visualisation of chromatin condensation with Hoechst 33342 (Mo-
lecular Probes, Eugene, OR, USA) was carried out as previously
described [5].
2.3. Immunoblotting
Protein was measured as described [5] and equivalent amounts of
cytosolic and nuclear proteins were resolved on SDS^polyacrylamide
gels and transferred to nylon-reinforced nitrocellulose (OptiTran,
Schleicher and Schuell, Dassel, Germany). Membranes were probed
with rabbit polyclonal antibodies against PARP (Roche Molecular
Biochemicals, Auckland, New Zealand), phospho-speci¢c CREB
(Ser-133) and CREB (gifts from Michael Comb, New England Bio-
labs, Beverly, MA, USA), caspase-9 (Pharmingen, San Diego, CA,
USA), caspase-6 (Biosource, Nivelles, Belgium), ERK (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), and caspase-3 (mouse mono-
clonal from Transduction Laboratories, Lexington, KY, USA). Pro-
teins were detected using horseradish peroxidase-conjugated anti-
rabbit and anti-mouse secondary antibodies (Amersham, Bucking-
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hamshire, UK) and immunoblots were visualised using enhanced
chemiluminescence Western blotting detection reagents (Amersham).
2.4. Staurosporine-induced apoptosis
Six to eight plates of con£uent SY5Y cells were washed and har-
vested in serum-free RPMI 1640 medium prior to reculturing for
various times at 37‡C in serum-free medium containing 0.5 WM stau-
rosporine. For the caspase activity assays, SY5Y cells recultured for
24 h in medium containing 10% foetal calf serum were used as a
control. Protein lysates were prepared from cells according to the
method of Wang et al. [22].
2.5. Caspase activity assays
Cleavage of the £uorogenic caspase substrates DEVD-AFC, IETD-
AFC, YVAD-AFC (Biomol) and VEID-AFC (Pharmingen) were
measured in a Perkin-Elmer LS50B luminescence spectrophotometer
(excitation 400 nm; emission 505 nm). Activities are expressed as fold
induction over a non-apoptotic control.
3. Results and discussion
We examined whether CREB was a¡ected during cyto-
chrome c-mediated apoptosis in extracts from neural cells.
Previously, we identi¢ed the pro-survival kinase Akt as a cas-
pase substrate during neural cell apoptosis using in vitro re-
constitution of apoptosis [5]. Exogenously added cytochrome
c activates the Apaf-1/caspase-9 signalling cascade [23] in cy-
tosol derived from human neuroblastoma (SY5Y) cells [5].
CREB was cleaved in the reactions where cytochrome c was
added to initiate the apoptotic mechanism, yielding a cleavage
fragment of approximately 30 kDa (Fig. 1A, lanes 2 and 5).
Production of this cleavage fragment of CREB correlated
with caspase-9 and caspase-3 activation, indicated by the pres-
ence of cleavage fragments p37 and p17, respectively (Fig.
Fig. 1. CREB cleavage during in vitro reconstitution of apoptosis is caspase-dependent. A: CREB cleavage is speci¢c and correlates with cas-
pase activation. Rat phaeochromocytoma (PC12) nuclei were incubated in the presence of cytosol harvested from growing human neuroblasto-
ma (SY5Y) cells, in the presence of an ATP-regenerating system (lanes 1^6, and 8) or an ATP-depleting system (lane 7), with the following ad-
ditions: cytochrome c (lanes 2^8), DEVD-CHO (lane 3), orthovanadate (lanes 4 and 6), okadaic acid (lanes 4 and 5), or z-VAD-FMK (lane 8).
Reactions were incubated at 37‡C for 4 h, after which the samples were analysed by immunoblotting using an antibody speci¢c for proteins la-
beled at the right of panels. The phospho-CREB antibody cross-reacts with the transcription factor ATF-1. Cleavage fragment sizes are indi-
cated for caspase-9, caspase-3, and CREB. The blot for ERK1/2, which is not a¡ected in these reactions, shows that equal protein was loaded
on the gel and that CREB was speci¢cally cleaved in the reactions where caspase cleavage and activation was detected. Data are representative
of four independent experiments. B: Caspase inhibitors inhibit CREB cleavage. SY5Y cytosol and PC12 nuclei were incubated together as in A
in the presence of an ATP-regenerating system, with cytochrome c (lanes 2^6), DEVD-CHO (lane 3), YVAD-CHO (lane 4), IETD-CHO (lane
5), and z-VAD-fmk (lane 6). After incubation, the samples were analysed by immunoblotting using an antibody speci¢c for proteins labeled at
the right of panels. The asterisk denotes an incompletely processed form of caspase-3. Only DEVD-CHO and z-VAD-fmk completely inhibited
CREB cleavage. Data are representative of ¢ve independent experiments. C and D: The amount of CREB cleavage in B correlates with the
amount of activity in the presence of peptide inhibitors. SY5Y cytosol and PC12 nuclei were incubated with an ATP-regenerating system and
cytochrome c as in A with the peptide inhibitors DEVD-CHO (lane 2), YVAD-CHO (lane 3), IETD-CHO (lane 4) or z-VAD-fmk (lane 5) as
in B. Caspase activity was measured by cleavage of substrates DEVD-AFC (C) and IETD-AFC (D). Caspase activities are expressed as fold in-
duction over a control reaction performed in the absence of cytochrome c. Results are averages of three experiments for reaction 1 and stan-
dard errors are indicated. Results are averages of two experiments for reactions 2^5 and ranges are indicated. E: CREB cleavage correlates
with apoptotic chromatin condensation. SY5Y cytosol and PC12 nuclei were incubated together as in A in the presence of an ATP-regenerating
system, with cytochrome c (lanes 2^6) and the peptide inhibitors shown. Nuclei were ¢xed and stained with Hoechst 33342 and scored for apo-
ptotic morphology. Results are averages of four independent experiments and standard errors are indicated.
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1A). CREB cleavage was speci¢c because there was no change
in the amounts of the control protein ERK (Fig. 1A). CREB
cleavage was inhibited in the presence of the caspase inhibi-
tors DEVD-CHO and z-VAD-fmk (Fig. 1A, lanes 3 and 8).
These results suggest that CREB can be cleaved by caspases
during apoptosis.
The activity of caspase-9 has been proposed to be nega-
tively regulated by phosphorylation [24]. We asked if inhib-
itors of tyrosine or serine/threonine phosphatases a¡ected the
apoptotic mechanism and CREB cleavage in our in vitro sys-
tem. The data suggest that phosphatases a¡ect the apoptotic
mechanism and CREB cleavage in our in vitro system. The
tyrosine phosphatase inhibitor orthovanadate did inhibit
CREB cleavage and caspase-3 and caspase-9 activation (Fig.
1A, lanes 4 and 6). The serine/threonine phosphatase inhibitor
okadaic acid by itself had no e¡ect on CREB cleavage or
caspase activation (Fig. 1A, lane 5). We detected a slight in-
crease in molecular weight in procaspase-9 in reactions con-
taining both orthovanadate and okadaic acid, but not each
individually [5] (Fig. 1A). This increase indicates that caspase-
9 is phosphorylated at both tyrosine and serine/threonine res-
idues. However, our data, and those of others, suggest that
only tyrosine phosphorylation regulates caspase-9 activity
[25,26].
Active CREB, phosphorylated at Ser-133, was detected in
reactions containing okadaic acid (Fig. 1A, lanes 4 and 5) but
not orthovanadate by itself (Fig. 1A, lane 6). Phospho-CREB
was also detected in lower amounts in the reactions containing
the caspase inhibitors DEVD-CHO and z-VAD-fmk (Fig. 1A,
lanes 3 and 8). The buildup of phospho-CREB in the presence
of caspase inhibitors suggests a relationship between the phos-
phorylation state of CREB and caspase-mediated cleavage.
Serine-133-phosphorylated CREB may be a preferred sub-
strate when caspase activity is low; in any case its presence
in the pool of total CREB had no e¡ect on CREB cleavage
(Fig. 1A, lane 5).
ATP is required for initiation of apoptosis in vitro [27] and
for caspase activation in the presence of cytochrome c (Fig.
1A). Interestingly, total CREB protein levels were reproduci-
bly decreased without production of the 30 kDa cleavage frag-
ment in reactions where ATP was depleted even though cas-
pase-3 and caspase-9 were not activated (Fig. 1A, lane 7).
To look more closely at the caspase dependence of CREB
cleavage, additional reactions were performed in the presence
of di¡erent caspase inhibitors (non-cleavable peptide sub-
strates, Fig. 1B^E). Only DEVD-CHO, which strongly inhib-
its caspase-3 and -7, and z-VAD-fmk (a general caspase in-
hibitor) completely blocked CREB cleavage. These inhibitors
blocked cleavage and activation of caspase-3, as well as cas-
pase-6 and caspase-9, which are cleaved by caspase-3 [28]
(Fig. 1B, lanes 3 and 6; Fig. 1C,D, reactions 2 and 5).
IETD-CHO (a caspase-6, -8 and -10 inhibitor) partially inhib-
ited caspase activation and CREB cleavage (Fig. 1B, lane 5;
Fig. 1C,D, reaction 4), while the caspase-1 inhibitor YVAD-
CHO had no e¡ect on caspase activation or CREB cleavage
(Fig. 1B, lane 4; Fig. 1C,D, reaction 3). The activity induced
by cytochrome c towards the DEVD substrate was many
times greater than towards IETD, but the relative inhibition
by non-hydrolysable analogues was similar (compare Fig. 1C
and D). The inhibitors that were most e¡ective in preventing
CREB cleavage were also the most e¡ective in preventing
chromatin condensation in nuclei (Fig. 1E). These data sug-
gest that CREB can be speci¢cally cleaved by caspases and
that CREB cleavage correlates with caspase activity and ap-
optosis in nuclei.
We asked whether CREB cleavage occurred in vivo in
SY5Y cells induced to undergo apoptosis by staurosporine.
CREB cleavage occurred 24 h following staurosporine treat-
ment, concomitant with cleavage of the caspase-3 substrate
PARP (Fig. 2A). Caspase activity was detected at 24 h
when measured using di¡erent £uorogenic substrates (Fig.
2B), even though the processing of caspase-3 and -9 was not
detected by immunoblotting until 48 h after staurosporine
treatment (Fig. 2A). At 48 h further degradation of CREB
protein was apparent.
The CREB sequence ILNDLSSD (137^144) suggests a cas-
pase-6 or -8 cleavage site, however, there was no measurable
induction of activity towards the IETD (caspases-6, -10, -8)
substrate, YVAD (caspase-1) or VEID (caspase-6; Fig. 2B).
Fig. 2. CREB cleavage during staurosporine-induced apoptosis cor-
relates with DEVD-speci¢c caspase activity. A: SY5Y cells were
treated with 0.5 WM staurosporine for the times indicated. Whole
cell lysates were then analysed by immunoblotting using antibodies
speci¢c for the proteins labeled at the right of the panels. Cleavage
fragments for CREB, PARP, caspase-3 and caspase-9 are indicated.
Weak signals of cleavage fragments for caspase-3 (p17) and caspase-
9 (p37) were seen only after 48 h of staurosporine treatment. Data
are representative of four independent experiments. B: SY5Y cells
were cultured for 24 h in the absence (control) or presence of 0.5
WM staurosporine and caspase activities were measured by cleavage
of peptide substrates DEVD-AFC (black bar), IETD-AFC (dark
grey bar), YVAD-AFC (white bar), and VEID-AFC (light grey
bar). Results are expressed as fold induction of caspase activity over
serum-recultured control. Results are averages from four indepen-
dent experiments and standard errors are indicated.
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Only DEVD-directed caspase activity was induced in the stau-
rosporine-treated cells (Fig. 2B). These data suggest that
CREB is a substrate for caspase-3 or -7 in vivo, which is
consistent with the in vitro data.
CREB appears to be a key target for destruction, being
downstream of both Raf-1 and Akt, which are also cleaved
by caspases, and upstream of the important survival protein,
Bcl-2. Why inactivate CREB by proteolysis, rather than by
dephosphorylation? Caspase-mediated cleavage of key pro-
teins involved in survival signalling makes their inactivation
irreversible and eliminates possible con£icting signals. That
this occurs at a late stage of apoptosis enforces no possibility
of escape from execution, and avoids a possibly messy ‘un-
dead’ state somewhere between life and death. In addition,
CREB may function without activation by phosphorylation.
It has been reported that non-phosphorylated CREB has anti-
apoptotic activity and can suppress AP-1 (c-Jun/c-Fos hetero-
dimer) transcriptional activity by competing for the AP-1
binding site on target genes [29].
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